Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:501 (2 September), doi:10.1136/bmj.333.7566.501-b
| The first 150 words of the full text of this article appear below. |
EDITORCollins and Rhodes, in their review of medical treatments for ulcerative colitis, cover surgical management options only very briefly, despite their acknowledgment that the overall colectomy rate is still about 25%.1 Their comment that colectomy may be needed if medical treatment does not produce a substantial response within seven to 10 days cannot go unchallenged.
Fifteen per cent of patients with ulcerative colitis will have a severe attack, requiring admission to hospital, at some time during their illness. These patients are traditionally treated with intravenous corticosteroids, with a response rate of 60%; the remaining 40% require colectomy, which essentially cures the patient. Persisting with medical treatment if the response is inadequate is dangerous. If surgery is delayed the patient's general condition may deteriorate and lead to a risk of multiple organ dysfunction syndrome,2 which may adversely affect the outcome.
Scoring systems for ulcerative colitis are useful in stratifying
Neil J Smart, specialist registrar general surgery
North Bristol NHS Trust drneilsmart@hotmail.com